...
...
Next Story

Four in 10 adults above 70 show reluctancy to vaccine: Study

The survey, conducted over the phone with 4000-plus participants, also found that 57% of the unvaccinated in the 70-plus age group were concerned with the safety or efficacy of the vaccine and 29% thought they were too old to receive the vaccine.

Updated on: Jul 6, 2021, 08:30:10 IST
Advertisement

Four in 10 unvaccinated adults above the age of 70 were hesitant to take the shot against the coronavirus disease (Covid-19), a survey commissioned by the government has said, highlighting the need for effective messaging on the ground among the target population group.

Individuals are considered vaccine-hesitant if they are unwilling or unsure about getting vaccinated. (HT Photo)
Individuals are considered vaccine-hesitant if they are unwilling or unsure about getting vaccinated. (HT Photo)

The survey, conducted over the phone with 4000-plus participants, also found that 57% of the unvaccinated in the 70-plus age group were concerned with the safety or efficacy of the vaccine and 29% thought they were too old to receive the vaccine.

Individuals are considered vaccine-hesitant if they are unwilling or unsure about getting vaccinated.

Click here for full Covid-19 coverage

Experts have been emphasising the need to counter vaccine hesitancy, especially among the elderly who are at high risk for developing severe forms of viral illness. According to the Union health ministry data, barely 50% of India’s population of 138 million people above the age of 60 have received at least one vaccine dose.

New Delhi’s AIIMS was assigned as the nodal centre for LASI, a study commissioned by the health ministry in 2016 to track ageing patterns and diseases affecting India’s elderly.

“As part of the longitudinal ageing study, we have a database of participants, and we made use of this database for this phone survey. We had their contact details as part of the larger study cohort and made use of it as the sub-sample. People were called and made to answer questions, especially designed keeping this survey in mind,” said Dr Dey, head of geriatrics department at the All India Institute of Medical Sciences (AIIMS), Delhi.

For the survey, apart from the participants, a family member or friend was also interviewed whom the participants nominated as informants.

“The Covid-19 pandemic has fundamentally altered the lives of individuals across the world, including India,” said excerpts from results documented as part of the survey that HT has accessed.

The survey underlined that some of the top reasons for vaccine hesitancy in India were concerns around its safety and effectiveness, being able to protect self, mistrust in government and companies, and being too old to receive the vaccine. It said extra attention may be needed to reach high levels of vaccination among one of the highest at-risk groups — older generations.

“Even before the start of the Covid-19 vaccination drive, the states were advised to focus on both the problems of vaccine hesitancy and vaccine eagerness. Several awareness campaigns were held by ground-level workers at the community level in all states,” said a senior government official aware of the matter, on condition of anonymity.

Public health expert Dr Chandrakant Lahariya said it is important to get to the root cause of vaccine hesitancy to be able to successfully deal with the issue. “It needs to be a thorough exercise done keeping in mind people belonging to different sections of society, residing in different areas, and age groups as persons belonging to different population groups will have a different reason for being hesitant about it,” said Dr Lahariya.

 
ABOUT THE AUTHOR
Rhythma Kaul

Rhythma Kaul is the national health editor of the Hindustan Times. She has been reporting on public health, medicine, and medical research, with a particular focus on how government decisions and health system reforms shape people’s lives. Rhythma has over 25 years of journalistic experience. She joined Hindustan Times in 2008, and has since covered everything from pandemics and infectious diseases to cutting‑edge medical research and climate‑related health challenges. Her stories routinely track the work of the Ministry of Health and Family Welfare, department of pharmaceuticals, and key national health programmes, making complex medical science and policy accessible to a wide audience. One of her prominent news breaks has been the 2012 Baby Falak case: A two-year-old brutally battered baby girl was admitted to AIIMS-Delhi with severe head injuries, multiple fractures, human bite marks, and burns. The police investigation revealed this to be a case of multi-state human-trafficking racket. She was profiled by The Wall Street Journal for breaking this story. Rhythma holds a Master’s degree from Jawaharlal Nehru University, Delhi. Prior to Hindustan Times, she worked with the India Today Group. Rhythma can be contacted at rhythma.kaul@hindustantimes.com. Her X handle is @RamblingBrook.

Get the latest India News, breaking headlines and real-time updates from across the country. Stay informed about politics, government policies, crime, weather and major national developments.
Get the latest India News, breaking headlines and real-time updates from across the country. Stay informed about politics, government policies, crime, weather and major national developments.
SHARE THIS ARTICLE ON
Hindustantimes wants to start sending you push notifications. Click allow to subscribe